Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis
Articolo
Data di Pubblicazione:
2020
Citazione:
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis / Olivera, Pablo A; Lasa, Juan S; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - 158:6(2020), pp. 1554-1573.e12. [10.1053/j.gastro.2020.01.001]
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
IBD; Immunosuppression; NMSC; Small Molecule; Arthritis; Rheumatoid; Azetidines; Herpes Zoster; Heterocyclic Compounds; 3-Ring; Humans; Incidence; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Piperidines; Placebos; Psoriasis; Pyridines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Spondylitis; Ankylosing; Sulfonamides; Survival Analysis; Treatment Outcome; Triazoles
Elenco autori:
Olivera, Pablo A; Lasa, Juan S; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent
Link alla scheda completa:
Pubblicato in: